3 High-Risk Biotechs That Could Pop or Drop in 2018 Post author:Sam Post published:February 4, 2018 Post category:BioPharma A look at three biotech companies that face make-or-break catalysts this year. Source: BioSpace You Might Also Like Booming Bay Area Biotechs' Huge Headache: Where to House Their Employees October 12, 2017 <b>KD&A</b> Release: Meeting Medical Software Regulatory Requirements July 20, 2017 Juno Finally Drops Problem CAR-T Drug That Caused Deaths March 1, 2017
